250 related articles for article (PubMed ID: 17693574)
1. A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals.
Konsti J; Lundin J; Jumppanen M; Lundin M; Viitanen A; Isola J
J Clin Pathol; 2008 Mar; 61(3):278-82. PubMed ID: 17693574
[TBL] [Abstract][Full Text] [Related]
2. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification.
Moelans CB; de Weger RA; van Diest PJ
Breast Cancer Res Treat; 2010 Feb; 120(1):1-7. PubMed ID: 19760503
[TBL] [Abstract][Full Text] [Related]
3. Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers: three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals.
Itoh H; Miyajima Y; Umemura S; Osamura RY
Cancer; 2008 Apr; 114(2):134-40. PubMed ID: 18306351
[TBL] [Abstract][Full Text] [Related]
4. Is it necessary to evaluate nuclei in HER2 FISH evaluation?
López C; Tomás B; Korzynska A; Bosch R; Salvadó MT; Llobera M; Garcia-Rojo M; Alvaro T; Jaén J; Lejeune M
Am J Clin Pathol; 2013 Jan; 139(1):47-54. PubMed ID: 23270898
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.
Francz M; Egervari K; Kardos L; Toth J; Nemes Z; Szanto J; Szollosi Z
J Clin Pathol; 2010 Apr; 63(4):341-6. PubMed ID: 19965795
[TBL] [Abstract][Full Text] [Related]
6. Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.
Bilous M; Morey A; Armes J; Cummings M; Francis G
Pathology; 2006 Apr; 38(2):120-4. PubMed ID: 16581651
[TBL] [Abstract][Full Text] [Related]
7. The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer.
Hyun CL; Lee HE; Kim KS; Kim SW; Kim JH; Choe G; Park SY
J Clin Pathol; 2008 Mar; 61(3):317-21. PubMed ID: 17761736
[TBL] [Abstract][Full Text] [Related]
8. Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer.
Mansfield AS; Sukov WR; Eckel-Passow JE; Sakai Y; Walsh FJ; Lonzo M; Wiktor AE; Dogan A; Jenkins RB
Am J Clin Pathol; 2013 Feb; 139(2):144-50. PubMed ID: 23355198
[TBL] [Abstract][Full Text] [Related]
9. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
Narath R; Lörch T; Rudas M; Ambros PF
Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
[TBL] [Abstract][Full Text] [Related]
10. An approach for quantitative assessment of fluorescence in situ hybridization (FISH) signals for applied human molecular cytogenetics.
Iourov IY; Soloviev IV; Vorsanova SG; Monakhov VV; Yurov YB
J Histochem Cytochem; 2005 Mar; 53(3):401-8. PubMed ID: 15750029
[TBL] [Abstract][Full Text] [Related]
11. [Examination of the increased speed of detection of HER-2/neu gene amplification in breast cancer by fluorescence in situ hybridization (FISH) using image analysis software].
Kuroso K; Murakami S; Jinnai M; Ueda Y
Rinsho Byori; 2006 May; 54(5):463-5. PubMed ID: 16789416
[TBL] [Abstract][Full Text] [Related]
12. Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?
Bartlett JM; Campbell FM; Mallon EA
Am J Clin Pathol; 2008 Dec; 130(6):920-6. PubMed ID: 19019769
[TBL] [Abstract][Full Text] [Related]
13. Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: A feasibility study.
Tubbs RR; Pettay JD; Swain E; Roche PC; Powell W; Hicks DG; Grogan T
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):436-40. PubMed ID: 17122642
[TBL] [Abstract][Full Text] [Related]
14. Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma.
Shah SS; Wang Y; Tull J; Zhang S
Diagn Mol Pathol; 2009 Mar; 18(1):30-3. PubMed ID: 19214111
[TBL] [Abstract][Full Text] [Related]
15. Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population.
Rygiel AM; van Baal JW; Milano F; Wang KK; ten Kate FJ; Fockens P; Rosmolen WD; Bergman JJ; Peppelenbosch MP; Krishnadath KK
Cancer; 2007 May; 109(10):1980-8. PubMed ID: 17385213
[TBL] [Abstract][Full Text] [Related]
16. Image enhancement for increased dot-counting efficiency in FISH.
Shah S
J Microsc; 2007 Nov; 228(Pt 2):211-26. PubMed ID: 17970921
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas.
Taniyama K; Ishida K; Toda T; Motoshita J; Kuraoka K; Saito A; Tani Y; Uike T; Teramoto S; Koseki M
Breast Cancer; 2008; 15(3):231-40. PubMed ID: 18264744
[TBL] [Abstract][Full Text] [Related]
18. The correlation between dual-color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene amplification in breast cancer.
Pedersen M; Rasmussen BB
Diagn Mol Pathol; 2009 Jun; 18(2):96-102. PubMed ID: 19430295
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens.
Shousha S; Peston D; Amo-Takyi B; Morgan M; Jasani B
Histopathology; 2009 Jan; 54(2):248-53. PubMed ID: 19207950
[TBL] [Abstract][Full Text] [Related]
20. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]